论文信息 - MA 02.10 Phase I Study of ABBV-399 (Telisotuzumab Vedotin) as Monotherapy and in Combination with Erlotinib in NSCLC - 字舞流文

MA 02.10 Phase I Study of ABBV-399 (Telisotuzumab Vedotin) as Monotherapy and in Combination with Erlotinib in NSCLC

R. Heist | K. Kelly | D. Camidge | L. Naumovski | M. Motwani | D. Morgensztern | J. Goldman | J. Strickler | H. Yue | M. Barve | E. Angevin | D. Afar | J. Beaulieu